SCHD ETF Daily Update, 2/19/2026
TipRanks (Thu, 19-Feb 8:13 AM ET)
Business Wire (Tue, 20-Jan 8:00 AM ET)
Carter's, Inc. Provides Business Update
Business Wire (Fri, 9-Jan 6:30 AM ET)
Carter’s Adjusts Strategy With Aggressive Cost Cuts and Store Closures as Profitability Slips
Market Chameleon (Mon, 27-Oct 7:55 AM ET)
Market Chameleon (Mon, 27-Oct 3:38 AM ET)
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
Carter's trades on the NYSE stock market under the symbol CRI.
As of February 19, 2026, CRI stock price climbed to $42.03 with 1,205,376 million shares trading.
CRI has a beta of 1.05, meaning it tends to be more sensitive to market movements. CRI has a correlation of 0.14 to the broad based SPY ETF.
CRI has a market cap of $1.53 billion. This is considered a Small Cap stock.
Last quarter Carter's reported $758 million in Revenue and $.74 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$.01.
In the last 3 years, CRI traded as high as $88.03 and as low as $23.38.
The top ETF exchange traded funds that CRI belongs to (by Net Assets): IJR, AVUV, SCHD, VTI, IWM.
CRI has underperformed the market in the last year with a return of -15.9%, while SPY returned +13.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CRI shares. However, CRI has outperformed the market in the last 3 month and 2 week periods, returning +48.1% and +9.3%, while SPY returned +4.0% and -0.2%, respectively. This indicates CRI has been having a stronger performance recently.
CRI support price is $39.70 and resistance is $42.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRI shares will trade within this expected range on the day.